Last reviewed · How we verify
Cortef — Competitive Intelligence Brief
marketed
Corticosteroid [EPC]
Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible
Oncology
Small molecule
Live · refreshed every 30 min
Target snapshot
Cortef (hydrocortisone) — Generic (originally Merck/Upjohn).
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cortef TARGET | hydrocortisone | Generic (originally Merck/Upjohn) | marketed | Corticosteroid [EPC] | Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible | 1952-01-01 |
| Cortisol | Cortisol | University of Zurich | marketed | Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible | ||
| Emflaza | DEFLAZACORT | Ptc Therap | marketed | Corticosteroid [EPC] | 2017-01-01 | |
| Fluocinolone Acetonide | FLUOCINOLONE | Eurofarma | marketed | Corticosteroid [EPC] | 2016-01-01 | |
| Arnuity Ellipta | FLUTICASONE FUROATE | Haleon Us Holdings | marketed | Corticosteroid | Glucocorticoid receptor | 2007-01-01 |
| Lotemax | LOTEPREDNOL ETABONATE | Bausch Health | marketed | Corticosteroid | Glucocorticoid receptor | 1998-01-01 |
| Pandel | HYDROCORTISONE PROBUTATE | ANI Pharmaceuticals | marketed | Corticosteroid | Glucocorticoid receptor | 1997-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
- — Cortef · 9717740 · Method of Use · US
- — Cortef · 9675559 · Method of Use · US
- — Lotemax · 10058511 · Formulation · US
- — Lotemax · 9056057 · Formulation · US
- — Lotemax · 11219596 · Method of Use · US
- — Lotemax · 11219597 · Method of Use · US
- — Lotemax · 11596599 · Method of Use · US
- — Lotemax · 10857096 · Method of Use · US
- — Lotemax · 10864219 · Method of Use · US
- — Lotemax · 10945948 · Method of Use · US
- — Lotemax · 10940108 · Method of Use · US
- — Lotemax · 9737491 · Method of Use · US
- — Lotemax · 9827191 · Formulation · US
- — Lotemax · 10993908 · Method of Use · US
- — Lotemax · 12115246 · Formulation · US
- — Lotemax · 10688045 · Formulation · US
- — Lotemax · 11642317 · Formulation · US
- — Lotemax · 10646437 · Formulation · US
- — Lotemax · 9393213 · Formulation · US
- — Lotemax · 10646436 · Formulation · US
- — Lotemax · 11872318 · Formulation · US
- — Lotemax · 9532955 · Method of Use · US
- — Cortef · 9649280 · Formulation · US
- — Lotemax · 11534395 · Formulation · US
- — Lotemax · 10596107 · Formulation · US
- — Cortef · 11904046 · Formulation · US
- — Cortef · 12133914 · Method of Use · US
Sponsor landscape (Corticosteroid [EPC] class)
- Eurofarma · 2 drugs in this class
- · 2 drugs in this class
- Astellas Pharma · 1 drug in this class
- AstraZeneca K.K. · 1 drug in this class
- Generic (originally Merck) · 1 drug in this class
- Generic (originally Merck/Upjohn) · 1 drug in this class
- Generic (originally Schering) · 1 drug in this class
- National Jewish Health · 1 drug in this class
- Padagis Us · 1 drug in this class
- Ptc Therap · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cortef CI watch — RSS
- Cortef CI watch — Atom
- Cortef CI watch — JSON
- Cortef alone — RSS
- Whole Corticosteroid [EPC] class — RSS
Cite this brief
Drug Landscape (2026). Cortef — Competitive Intelligence Brief. https://druglandscape.com/ci/hydrocortisone. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab